All In Biotech

Free tool

FAERS Monitor: Potassium Chloride 0.22% In Dextrose 5% and Sodium Chloride 0.9% In Plastic Container

The FDA Adverse Event Reporting System collects reports from patients, clinicians and manufacturers. Counts are unverified reports, not rates: they rise with how widely a drug is used, how long it has been sold and media attention, a report can name several drugs, and a report does not show the drug caused the event.

Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations

Reports naming NDA 019630 or its brand name (Potassium Chloride 0.22% In Dextrose 5% and Sodium Chloride 0.9% In Plastic Container, Dextrose, Potassium Chloride, Sodium Chloride). Reports on generic versions are filed under their own applications.

Reports

43

Serious

31

72% of reports

Hospitalization

9

Death reported

17

Any cause; not necessarily from the drug

Most reported reactions

MedDRA preferred terms.

  • death16
  • infusion related reaction4
  • product packaging confusion3
  • blood potassium increased2
  • dyspnoea2
  • flushing2
  • physical product label issue2
  • product label confusion2
  • product label issue2
  • product selection error2
  • vomiting2
  • abdominal distension1
  • anaphylactic reaction1
  • atrial fibrillation1
  • atrial flutter1

Reports by year received

View as table
YearReports
20121
20131
201417
20155
20162
20174
20191
20213
20225
20231
20241
20251
20261

Disproportionality screen

Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,054,116 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.

ReactionReportsPRR95% CI lowerChi-squared
product selection error2894.3230.81,001
physical product label issue2824.3212.7923
product packaging confusionSignal3605.2203.11,254
product label confusion2167.943.4186
product label issue2144.237.3159
atrial flutter161.38.814
blood potassium increased260.315.665
infusion related reactionSignal429.511.684
flushing29.62.58
deathSignal169.16.2112
anaphylactic reaction18.91.31
atrial fibrillation15.00.70
abdominal distension14.70.70
vomiting22.10.50
dyspnoea21.70.40

A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.